Kathryn “Kate” Audette, MSW

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Director of Government Affairs

Important Policy Initiatives Towards Eliminating the Racial Disparity    Watch Video

Kathryn “Kate” Audette currently serves as the Director of Government Affairs at the Dana-Farber Cancer Institute. In this role she develops patient, family, caregiver and provider driven advocacy campaigns in order to create positive impact in the areas of cancer prevention, access to care, health equity and survivorship quality of life.

Prior to this role Kate served for seven years as the Director of State Government Relations at Boston Children’s Hospital where she provided strategic oversight and leadership of the hospital’s state policy advocacy agenda on child health priorities.

A results driven, government relations professional with a demonstrated history of working in the health care industry, Kate is skilled in policy practice, grassroots organizing and program evaluation. A social worker by training, Kate has a deep commitment to community, equity and educating the next generation of social workers.

Deeply committed to community service, Kate serves a board member at Harbor Health Services, a community health organization and Project Bread a nonprofit dedicated to preventing and ending hunger in Massachusetts.

Jay K. Jhaveri, MD, MPH

Bayer US LLC, Pharmaceuticals

Bayer US LLC, Pharmaceuticals

Director, Medical Affairs, Oncology

Variance in Symptom Assessment Between Patient and Caregiver    Watch Video
Dr. Jhaveri received his Medical Doctorate and began his career in general surgery residency at the New York Medical College. Following completion of prostate cancer outcomes research fellowships in robotic surgery and Men’s Health, he subsequently became a urology resident at the University of California, Irvine. He also completed a clinical fellowship in minimally invasive urologic surgery at the Henry Ford Health System’s – Vattikuti Urology Institute. He holds a Master of Public Health degree in Epidemiology and Biostatistics and his clinical research
interests include prostate cancer outcomes, real-world evidence, and data generation relevant to knowledge gap elucidation.
He has previously served as Director of Clinical Development / Health Economics Outcomes Research and within Medical Affairs divisions at various organizations. He currently serves as the Director, Medical Affairs Oncology – Prostate at Bayer Healthcare.

Ms. Ann Marie Dawidczyk

Blue Earth Diagnostics

Blue Earth Diagnostics

Vice President Patient Access and Advocacy

Next Generation Precision Radiopharmaceuticals for Patients with Cancer    Watch Video

Ann Marie is the Vice President of Patient Access and Advocacy at Blue Earth Diagnostics. She leads a team focused on educating customers and patients about prostate imaging, developing health policy, working with legislators and government officials, and advocating for change. She also is the Chair of the Medical Imaging & Technology Alliance (MITA) PET Coding, Coverage and Payment Committee.

She was previously the lead of US Policy and Reimbursement Strategy at GE Healthcare Pharmaceutical Diagnostics. Prior to GE she held market access roles at LifeCell, Genzyme Tissue Repair, Smith & Nephew and Johnson and Johnson. Her career has focused on removing patient access barriers to innovative medical technologies including tissue regeneration products, diagnostics and chronic wound treatments.

Ann Marie holds a Bachelor of Science degree in Health Sciences and Administration from Simmons College.

Magnolia Contreras, MSW, MBA

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Vice President for Community Health

Understanding Social Determinants of Health and Impact on the Prostate Cancer Racial Disparity    Watch Video

Ms. Contreras joined Dana-Farber in 2007 and currently oversees the Community Health and Community Benefits programs. In this role, she is charged with helping the Institute carry out its Community Benefits mission through the delivery of evidence-based cancer prevention, screening and early detection programs and working across the cancer continuum to help improve cancer care outcomes for medically underserved populations.

The role of Dana-Farber’s Community Benefits office is to support the Institute’s goal to reduce cancer risk among medically underserved populations. Ms. Contreras and her teamwork with city and state health departments, community partners, and Boston-based coalitions to assess and monitor the needs of local residents with respect to cancer control. They are on the front lines of supporting and collaborating on programs designed to eliminate disparities in breast, colon, and skin cancer; educate diverse populations about tobacco cessation, human papillomavirus (HPV) prevention and screening; and strengthen the support system for medically underserved populations. They are committed to making Dana-Farber’s care and research findings more accessible to everyone within and outside its walls.

Ms. Contreras is a graduate of Boston College, Simmons College Graduate School of Social Work and Suffolk University Sawyer Business School. She has been an Adjunct Faculty member in the Graduate School of Social Work at Salem State University, Simmons College and Boston College.

Hala Borno, MD

Helen Diller Family Comprehensive Cancer Center

Helen Diller Family Comprehensive Cancer Center

Assistant Clinical Professor, Genitourinary Oncology Program, University of California, San Francisco

Financial Toxicities and How Access to Treatment are Affected     Watch Video

Dr. Hala Borno is faculty at UCSF and an Assistant Professor in the Department of Medicine and Division of Hematology/Oncology and co-Medical Director of the Genitourinary Medical Oncology Clinic at the Helen Diller Family Comprehensive Cancer Center (HDFCCC) at the University of California San Francisco (UCSF). Dr. Borno is a medical oncologist with clinical expertise in the management of advanced urologic malignancies such as prostate, kidney, bladder, and testicular cancers. At HDFCCC, Dr. Borno serves on the executive leadership committee for the Prostate Cancer Program and the Liaison to the Office of Community Engagement. She is also a member of

the American Society of Clinical Oncology Social Determinants of Health working group, and GU committee for NRG oncology. She serves as the Vice Chair of the Health Disparities Committee for Alliance for Clinical Trials in Oncology.

Dr. Borno’s research program consists of prostate cancer therapeutic development and cancer disparities. She serves as medical oncology co-chair for phase III clinical trials and is the principal investigator for clinical trials conducted at HDFCCC in advanced prostate cancer. Dr. Borno has an extensive research program on the promotion of equity in cancer precision medicine.

She has developed novel recruitment technologies that are clinician and patient facing to promote diversity and inclusion of racial/ethnic minorities in clinical trials. Dr. Borno used human-centered design to develop Trial LibraryTM, a patient facing clinical trial matching tool. Dr. Borno’s research has been featured in peer-reviewed journals such JAMA Oncology, Cancer, and Nature. Her work has been covered by national news outlets such as NPR, Washington Post, CBS News, Bloomberg News, and STAT News.

Dr. Borno graduated with honors in biochemistry and received her medical degree from the University of North Carolina at Chapel Hill where she was a Medical Alumni Loyalty Fund Scholar. She completed her internal medicine residency and medical oncology fellowship training at UCSF. She served as chief oncology fellow at UCSF and was a National Institute on Aging T32 research fellow in the Division of Geriatrics.

Jacob Berchuck, MD

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Medical Oncologist

Considerations for the Management of Advanced Prostate Cancer    Watch Video

Dr. Jacob Berchuck is a Medical Oncologist in the Lank Center for Genitourinary Oncology at Dana-Farber/Brigham and Women’s Cancer Center. Dr. Berchuck received his undergraduate and medical degrees from Duke University. He trained in Internal Medicine at the University of California San Francisco. He then completed a fellowship in Medical Oncology at the Dana-Farber Cancer Institute. In addition to caring for patients, Dr. Berchuck conducts research using cell-free DNA to develop “liquid biopsies” for early and accurate cancer detection.